Tue, April 2, 2024

Michael Leithead Maintained (CC) at Hold with Decreased Target to $30 on, Apr 2nd, 2024

Michael Leithead of Barclays, Maintained "The Chemours Company" (CC) at Hold with Decreased Target from $32 to $30 on, Apr 2nd, 2024.

Michael has made no other calls on CC in the last 4 months.



There is 1 other peer that has a rating on CC. Out of the 1 peers that are also analyzing CC, 0 agree with Michael's Rating of Hold.



This is the rating of the analyst that currently disagrees with Michael


  • John McNulty of "BMO Capital" Downgraded from Buy to Sell and Decreased Target to $19 on, Friday, March 1st, 2024